Compile Data Set for Download or QSAR
maximum 50k data
Found 22 Enz. Inhib. hit(s) with all data for entry = 2548
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370883(US10239840, Example 13)
Affinity DataIC50:  4nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370878(US10239840, Example 8)
Affinity DataIC50:  4nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370880(US10239840, Example 10)
Affinity DataIC50:  5nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370875(US10239840, Example 5)
Affinity DataIC50:  5nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370877(US10239840, Example 7)
Affinity DataIC50:  5nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370892(US10239840, Example 21)
Affinity DataIC50:  8nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370881(US10239840, Example 11)
Affinity DataIC50:  9nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370893(US10239840, Example 22)
Affinity DataIC50:  9nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370888(US10239840, Example 17)
Affinity DataIC50:  10nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370889(US10239840, Example 18)
Affinity DataIC50:  13nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370886(US10239840, Example 16)
Affinity DataIC50:  13nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370879(US10239840, Example 9)
Affinity DataIC50:  14nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370884(US10239840, Example 14)
Affinity DataIC50:  17nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370882(US10239840, Example 12)
Affinity DataIC50:  19nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370871(US10239840, Example 1)
Affinity DataIC50:  27nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370874(US10239840, Example 4)
Affinity DataIC50:  34nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370891(US10239840, Example 20)
Affinity DataIC50:  42nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370876(US10239840, Example 6)
Affinity DataIC50:  60nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370872(US10239840, Example 2)
Affinity DataIC50:  76nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370885(US10239840, Example 15)
Affinity DataIC50:  77nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370890(US10239840, Example 19)
Affinity DataIC50:  92nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein Tax-1(Human T-cell leukemia virus 1 (strain Japan ATK-1 ...)
Viiv Healthcare

US Patent
LigandPNGBDBM370873(US10239840, Example 3)
Affinity DataIC50:  219nMAssay Description:Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent